Observational studyHypertension research : official journal of the Japanese Society of Hypertension2023
Feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring: A real-world prospective observational study.
Observational study in Hypertension research : official journal of the Japanese Society of Hypertension, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Comparison of blood pressure measurements between the Huawei Watch D smartwatch application and the validated Omron M3 Intellisense device: Observational study.Experimental physiology · 2026Observational
- Updates in the 2025 AHA/ACC Hypertension Guideline.Current hypertension reports · 2026Review
- Feasibility and performance evaluation of PPG on a Galaxy Watch in continuous central blood pressure monitoring.European heart journal. Digital health · 2026Article
- Wearable, cuffless, and portable devices for blood pressure monitoring (2015-2025): a scoping review of technologies, calibration, clinical validation, and regulatory frameworks.Frontiers in digital health · 2026Article
- To be (IIb), or not to be (IIb) - That is the current status of cuffless blood pressure monitoring device.Clinical hypertension · 2026Review
- Digital hypertension - what we need for the high-quality management of hypertension in the new era.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Review
- Cuffless Blood Pressure Measurement: Where Do We Actually Stand?Hypertension (Dallas, Tex. : 1979) · 2025Review
- Hypertension research 2024 update and perspectives: blood pressure management.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Review
- Cuffless Blood Pressure Monitor for Home and Hospital Use.Sensors (Basel, Switzerland) · 2025Review
- Feasibility of watch-based blood pressure monitoring device in daily blood pressure monitoring.Clinical hypertension · 2025Article
- The Role of Wearable Devices in Blood Pressure Monitoring and Hypertension Management: A Systematic Review.Cureus · 2024Review
- Medication Management Initiatives Using Wearable Devices: Scoping Review.JMIR human factors · 2024Article
- Examining the challenges of blood pressure estimation via photoplethysmogram.Scientific reports · 2024Article
- Exploring the link between blood pressure variability and atrial fibrillation: current insights and future directions.Journal of human hypertension · 2024Review
- History and evolution of blood pressure measurement.Clinical hypertension · 2024Review
- Long-term accuracy and stability of blood pressure measurements from a smartwatch: Prospective validation study.Digital healthArticle
Corrections and comments
- Commented on by
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cuffless wearable devices are currently being developed for long-term monitoring of blood pressure (BP) in patients with hypertension and in apparently healthy people. This study evaluated the feasibility and measurement stability of smartwatch-based cuffless BP monitoring in real-world conditions. Users of the first smartwatch-based cuffless BP monitor approved in Korea (Samsung Galaxy Watch) were invited to upload their data from using the device for 4 weeks post calibration. A total of 760 participants (mean age 43.7 ± 11.9, 80.3% men) provided 35,797 BP readings (average monitoring 22 ± 4 days [SD]; average readings 47 ± 42 per participant [median 36]). Each participant obtained 1.5 ± 1.3 readings/day and 19.7% of the participants obtained measurements every day. BP showed considerable variability, mainly depending on the day and time of the measurement. There was a trend towards higher BP levels on Mondays than on other days of the week and on workdays than in weekends. BP readings taken between 00:00 and 04:00 tended to be the lowest, whereas those between 12:00 and 16:00 the highest. The average pre-post calibration error for systolic BP (difference in 7-day BP before and after calibration), was 6.8 ± 5.6 mmHg, and was increased with higher systolic BP levels before calibration. Smartwatch-based cuffless BP monitoring is feasible for out-of-office monitoring in the real-world setting. The stability of BP measurement post calibration and the standardization and optimal time interval for recalibration need further investigation.
Indexed as
Identifiers
36781979What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.